| SpectraBase Spectrum ID |
3aSyqvaB3nV |
| Name |
trans-4-Methyl-4-methylaminorex |
| Classification |
Central stimulant, designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.11 (f) (5) |
| DEA Controlled Substance Name |
4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine |
| DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
| DEA Controlled Substances Code Number |
1595 |
| DEA Schedule |
Schedule I |
| DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers. |
| Exact Mass |
190.110613078 u |
| Formula |
C11H14N2O |
| InChI |
InChI=1S/C11H14N2O/c1-7-3-5-9(6-4-7)10-8(2)13-11(12)14-10/h3-6,8,10H,1-2H3,(H2,12,13)/t8-,10+/m0/s1 |
| InChIKey |
NPILLHMQNMXXTL-WCBMZHEXSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
190.246 g/mol |
| Nominal Mass |
190 u |
| Quality |
891 |
| Retention Index |
1654 |
| SMILES |
NC=1O[C@]([C@@](N1)(C)[H])(C=1C=CC(=CC1)C)[H] |
| SPLASH |
splash10-00tg-8900000000-904ba9294ac3fd329017 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
trans-4,4'-DMAR
trans-2-Amino-4-methyl-5-(4-methylphenyl)[4H]oxazoline |
| Technique |
GC/MS |
| Wiley ID |
DD2024_021921 |
